Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
复制标题
B7-H4的上调促进肝内胆管癌的肿瘤进展
DOI:
10.1038/s41419-017-0015-6
复制
发表时间:
2017-12-13
影响因子:
9
通讯作者:
Shi GM
中科院分区:
文献类型:
--
作者:
Xie N;Cai JB;Zhang L;Zhang PF;Shen YH;Yang X;Lu JC;Gao DM;Kang Q;Liu LX;Zhang C;Huang XY;Zou H;Zhang XY;Song ZJ;Sun HX;Fu BM;Ke AW;Shi GM
Recent reports show that B7-H4 is highly expressed in a variety of tumor cells, functions as a negative regulator of T cells and then promotes tumor progression. However, its expression and role in intrahepatic cholangiocarcinoma (ICC) remain unclear. In present study, B7-H4 expression in ICC and peritumoral tissues was determined at the level of mRNA and protein, and its bioactivity in ICC cells was studied after modification of B7-H4 expression. Then, the mechanism related to tumor progression induced by B7-H4 expression in ICC cells was explored. Finally, clinical significance of B7-H4 expression in ICC patients was further analyzed. The results showed that B7-H4 expression in ICC was much higher than that in peritumoral tissues at the level of both mRNA and protein. The high level of B7-H4 in ICC cells induced epithelial-to-mesenchymal transitions and promoted invasion and metastasis of tumor cells through activation of ERK1/2 signaling. The elevated B7-H4 expression was associated with the downregulated Bax, upregulated Bcl-2 expression, and activation of caspase-3. Clinically, high B7-H4 expression in tumor samples was significantly related to malignant phenotype, such as lymph node metastasis, high tumor stage, and poor differentiation. ICC patients with high expression of B7-H4 had shorter overall survival (OS) and disease-free survival. Moreover, the B7-H4 expression was an independent prognostic factor for predicting OS and tumor recurrence of ICC patients after operation. In conclusion, high expression of B7-H4 promotes tumor progression of ICC and may be a novel therapeutic target for ICC patients.
登录
查看更多内容
影响因子:
9.7
作者:
Song, Hyunkeun;Park, Gabin;Hur, Dae Young
通讯作者:
Hur, Dae Young
影响因子:
--
作者:
Chong DQ;Zhu AX
通讯作者:
Zhu AX
DOI:
10.1158/1078-0432.ccr-15-0858
发表时间:
2016-06-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Yao Y;Ye H;Qi Z;Mo L;Yue Q;Baral A;Hoon DSB;Vera JC;Heiss JD;Chen CC;Zhang J;Jin K;Wang Y;Zang X;Mao Y;Zhou L
通讯作者:
Zhou L
影响因子:
254.7
作者:
Torre, Lindsey A.;Bray, Freddie;Jemal, Ahmedin
通讯作者:
Jemal, Ahmedin
影响因子:
13.5
作者:
Huang, Xiao-Yong;Ke, Ai-Wu;Zhou, Jian
通讯作者:
Zhou, Jian